BENZAMYCIN Drug Patent Profile
✉ Email this page to a colleague
When do Benzamycin patents expire, and when can generic versions of Benzamycin launch?
Benzamycin is a drug marketed by Valeant Intl and is included in one NDA.
The generic ingredient in BENZAMYCIN is benzoyl peroxide; erythromycin. There are seventeen drug master file entries for this compound. Three suppliers are listed for this compound. Additional details are available on the benzoyl peroxide; erythromycin profile page.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for BENZAMYCIN?
- What are the global sales for BENZAMYCIN?
- What is Average Wholesale Price for BENZAMYCIN?
Summary for BENZAMYCIN
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Finished Product Suppliers / Packagers: | 2 |
| Raw Ingredient (Bulk) Api Vendors: | 103 |
| Patent Applications: | 4,144 |
| Drug Prices: | Drug price information for BENZAMYCIN |
| What excipients (inactive ingredients) are in BENZAMYCIN? | BENZAMYCIN excipients list |
| DailyMed Link: | BENZAMYCIN at DailyMed |
US Patents and Regulatory Information for BENZAMYCIN
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Valeant Intl | BENZAMYCIN | benzoyl peroxide; erythromycin | GEL;TOPICAL | 050557-001 | Oct 26, 1984 | AB | RX | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
